- Home
- WCC vs LNTH Comparison
WCC vs LNTH Comparison
Compare WCC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WCC
- LNTH
- Stock Information
- Founded
- WCC 1922
- LNTH 1956
- Country
- WCC United States
- LNTH United States
- Employees
- WCC N/A
- LNTH N/A
- Industry
- WCC Telecommunications Equipment
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WCC Consumer Discretionary
- LNTH Health Care
- Exchange
- WCC Nasdaq
- LNTH Nasdaq
- Market Cap
- WCC 8.0B
- LNTH 7.5B
- IPO Year
- WCC 1999
- LNTH 2015
- Fundamental
- Price
- WCC $162.69
- LNTH $80.44
- Analyst Decision
- WCC Buy
- LNTH Strong Buy
- Analyst Count
- WCC 7
- LNTH 5
- Target Price
- WCC $215.14
- LNTH $133.80
- AVG Volume (30 Days)
- WCC 782.9K
- LNTH 1.2M
- Earning Date
- WCC 05-01-2025
- LNTH 05-07-2025
- Dividend Yield
- WCC 1.11%
- LNTH N/A
- EPS Growth
- WCC 10.34
- LNTH N/A
- EPS
- WCC 13.26
- LNTH 3.53
- Revenue
- WCC $21,812,500,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- WCC $3.45
- LNTH $5.81
- Revenue Next Year
- WCC $4.43
- LNTH $12.26
- P/E Ratio
- WCC $12.33
- LNTH $22.78
- Revenue Growth
- WCC N/A
- LNTH 12.53
- 52 Week Low
- WCC $125.21
- LNTH $74.34
- 52 Week High
- WCC $216.17
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- WCC 54.66
- LNTH 27.72
- Support Level
- WCC $156.35
- LNTH $100.96
- Resistance Level
- WCC $165.29
- LNTH $108.91
- Average True Range (ATR)
- WCC 5.94
- LNTH 3.90
- MACD
- WCC 1.16
- LNTH -2.36
- Stochastic Oscillator
- WCC 88.77
- LNTH 5.07
About WCC WESCO International Inc.
Wesco International is an industrial distributor that has three reportable segments, electrical and electronic solutions, communications and security solutions, and utility and broadband solutions. The company offers more than 1.5 million products to its 140,000 active customers through a distribution network of 800 branches, warehouses, and sales offices, including 43 distribution centers. Wesco generates approximately 74% of its sales in the United States, but it has a global reach, with operations in 50 other countries.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.